Brief: Rallybio Q1 basic EPS of USD -0.43
09/05/2023 13:09
May 9 (Reuters) - Rallybio Q1 basic EPS USD -0.43. * Q1 operating expenses USD 18.374 million * Q1 net income USD -17.318 million * Q1 income from operations USD -18.374 million
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx